Perioperative management and clinical outcome of LVAD patients undergoing THA: A retrospective case series of 11 patients

25dkou017 10.3205/25dkou017 urn:nbn:de:0183-25dkou0174 Meeting Abstract Perioperative management and clinical outcome of LVAD patients undergoing THA: A retrospective case series of 11 patients Hansberg Hansberg Jobst Leopold JL

Center for Musculoskeletal Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Deutschland

author Hu Hu Xiaojun X

author Pidgaiska Pidgaiska Olga O

author Goumenos Goumenos Stavros S

author Reinecke Reinecke Pia P

author Stöckle Stöckle Ulrich U

author Perka Perka Carsten C author Mueller Mueller Markus M

German Heart Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Deutschland

author Meller Meller Sebastian S author German Medical Science GMS Publishing House

Düsseldorf

610 20251031 engl This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). M0634 017 Deutsche Gesellschaft für Orthopädie und Unfallchirurgie Deutsche Gesellschaft für Orthopädie und Orthopädische Chirurgie Deutsche Gesellschaft für Unfallchirurgie Berufsverband für Orthopädie und Unfallchirurgie Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2025) Poster | Hüft- und Beckenchirurgie Berlin 20251028 20251031 AB12-4377 TextObjectives and questions: Left ventricular assist devices (LVADs) are commonly utilized in severe left-sided heart disease as a bridge to transplantation or long-term treatment. Total hip arthroplasty (THA) improves mobility in these patients but entails numerous perioperative risks. Our study focused on perioperative management and clinical outcomes for LVAD patients undergoing THA, aiming to provide insights into this complex setting.Material and methods: We retrospectively analyzed patients with LVADs who underwent THA at our institution from May 2019 to November 2023. The outcomes of interest were perioperative anticoagulation management, thrombotic or bleeding events, transfusion needs, mortality, surgical site complications and reoperations. The functional outcome was evaluated using the modified Harris Hip Score (mHHS) and the EQ-5D quality of life score at their last follow-up.Results: The cohort consisted of 11 male patients, mean age 68.1 years. Patient survival was recorded over a 22.8-month mean follow-up (range, 1 to 53). Seven patients (63.6%) required postoperative transfusions and 5/11 patients (45.5%) experienced thromboembolic events. The mean hospital stay after THA was 13.5 days. The overall mortality related-to-disease rate in our series of LVAD patients undergoing primary THA was 27%. Three patients (27.3%) developed surgical site hematomas, which required one additional reoperation，one of those was infected. Hip functionality improved markedly, with the mean mHHS rising from 27.5 to 72.3.Discussion and conclusions: THA in LVAD patients is challenging yet feasible, offering significant functional improvements despite the increased perioperative morbidity. Mortality was associated with their underlying disease, but not the surgery. 0 0 0 0